RxDoctor Payments Data

Roberto Viau Colindres, MD

Infectious Disease · Burr Ridge, ILNPI 1700154028

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,000 of the $25,000 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Genentech, Inc.. Among infectious disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,000in general payments, 2019–2025

Across 1 payment — averaging $25,000 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$25K
$17,164in research payments, 2019–2025

Across 2 payments — averaging $8582.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$17K

What the payments were for

  • Grants$25,000100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.1$25,000

How this compares

$25,000 in reported general payments places this provider in the 90th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Medicare billing

Part B allowed, 2024
$339,976
Medicare patients
559
Services billed
11,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin21$11,218
Vancomycin Hcl32$6,501
CeftriaxoneCeftriaxone Sodium36$4,404
Methenamine Hippurate17$1,205
Cefadroxil16$612
Doxycycline Hyclate18$342
Doxycycline Monohydrate15$237
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$97
Metronidazole11$85

Paid to pharmacies, not to this prescriber.

Other infectious disease in Burr Ridge

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →